Terbinafin-Reference-Cited by-同舟云学术

Terbinafin

Published:2016-07-29 Issue:9 Volume:67 Page:718-723
ISSN:0017-8470
Container-title:Der Hautarzt
language:de
Short-container-title:Hautarzt

Author:

Dürrbeck A.,Nenoff P.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

http://link.springer.com/content/pdf/10.1007/s00105-016-3853-8.pdf

Reference15 articles.

1. Abdel-Rahman SM, Gotschall R, Kauffman RE et al (1999) Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin Pharmacol Ther 65:465–472

2. http://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/druginteractionslabeling/ucm093664.htm#classInhibit . Zugegriffen: 20. Mai 2016

3. Hynninen VV, Olkkola KT, Bertilson L et al (2008) Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine. Clin Pharmacol Ther 83:342–348

4. Lamisil® 250 mg Tabletten. Fachinformation, Stand September 2013. http://www.fachinfo.de/suche/fi/004734 . Zugegriffen: 14. Juni 2016

5. Madani S, Barilla D, Cramer J et al (2002) Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers. J Clin Pharmacol 42:1211–1218

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Efficacy and Safety of Topical Nanoliposomal Amphotericin B 0.4% Gel as a Potential Treatment for Onychomycosis: An Interventional Pilot Clinical Study;Dermatologic Therapy;2023-10-16

2. S1‐Leitlinie Onychomykose;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-06

3. S1 Guideline onychomycosis;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-05-22

4. Tinea capitis bei Kindern - ein buntes Krankheitsbild;hautnah dermatologie;2023-05

5. Molecular Mechanisms of Antifungal Resistance in Mucormycosis;BioMed Research International;2022-10-13